Position history

MARSHALL WACE, LLP

13F holdings history for

SYRE · Spyre Therapeutics Inc.

Ticker: SYRE
Investment type: Equity
Class: COM NEW
Manager: Marshall Wace, LLP - Marshall Wace

Holdings date	Value ($000s)	% of holdings	Shares	Filing date	All 13F holders